阿维莫泮与开腹及腹腔镜结肠节段切除术住院时间缩短相关
基于Vizient数据库2015至2017年12,727例开腹和腹腔镜结肠节段切除术患者,其中3,358例(26.4%)接受阿维莫泮。阿维莫泮与开腹和腹腔镜组住院时间均缩短相关,开腹手术直接成本降低7%,腹腔镜手术无成本差异。
要点
- 阿维莫泮与开腹和腹腔镜结肠切除住院时间缩短均相关
- 开腹手术中阿维莫泮与直接成本降低7%相关
- 腹腔镜手术中阿维莫泮未显示成本差异
核心结论
- 阿维莫泮与开腹和腹腔镜结肠节段切除术住院时间缩短相关,开腹手术成本降低,腹腔镜手术无成本差异。
研究设计与样本
- 回顾性数据库研究,查询Vizient数据集2015至2017年开腹和腹腔镜结肠节段切除术患者,共12,727例符合标准,3,358例(26.4%)接受阿维莫泮。
主要发现
- 开腹组未调整住院时间阿维莫泮组4.0天 vs 非阿维莫泮组6.0天(P < .01),调整后效应比0.79(P < .01)。
- 腹腔镜组未调整住院时间阿维莫泮组3.0天 vs 非阿维莫泮组4.0天(P < .01),调整后效应比0.85(P < .01)。
- 调整后阿维莫泮与直接成本降低7%相关(效应比0.93,P = .04)。
- 腹腔镜手术中阿维莫泮无成本差异(效应比0.99,P = .71)。
临床怎么用
- 在开腹和腹腔镜结肠节段切除术围术期可考虑使用阿维莫泮以缩短住院时间,开腹手术还可能降低直接成本。
局限性
- 研究为回顾性数据库分析,阿维莫泮效应未与其他加速康复外科措施完全隔离。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Alvimopan has been shown to reduce length of stay after bowel resection. Use remains variable among institutions due to cost and efficacy concerns in laparoscopic surgery. Additionally, alvimopan's effects have not been isolated from other medications within enhanced recovery protocols. The aim of this study was to distinguish the relationship between alvimopan use, length of stay, and cost in both open and laparoscopic segmental colectomies. METHODS: The Vizient dataset was queried to identify patients undergoing open and laparoscopic colectomies from 2015 to 2017. Patient demographics and treatment details were collected. Primary outcomes of interest included duration of stay and total direct costs. RESULTS: In the study, 12,727 patients met inclusion criteria and 3,358 (26.4%) received alvimopan. For both open and laparoscopic groups, alvimopan was associated with decreased length of stay in unadjusted (4.0 vs 6.0 days, P < .01 and 3.0 vs 4.0 days, P < .01, respectively) and adjusted analysis (effect ratio 0.79, P < .01 and 0.85, P < .01, respectively). Alvimopan was associated with a 7% decrease in direct cost after adjustment (effect ratio 0.93, P = .04), with no cost difference in laparoscopic procedures (effect ratio 0.99, P = .71). CONCLUSION: Alvimopan use is associated with decreased length of stay for both open and laparoscopic colon resections, decreased cost in open procedures, and no cost difference for laparoscopic procedures.
引用
- Henning RE, Hu KY, Rein LE, et al. Alvimopan is associated with decreased length of stay for both open and laparoscopic segmental colectomy. Surgery. 2019. PMID: 31345565. doi:10.1016/j.surg.2019.04.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。